PAVmed Inc. (PAVM)
NASDAQ: PAVM · IEX Real-Time Price · USD
2.140
-0.555 (-20.59%)
At close: Mar 28, 2024, 4:00 PM
2.268
+0.128 (5.98%)
After-hours: Mar 28, 2024, 6:14 PM EDT

PAVmed Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Net Income
-66.27-89.26-50.63-34.56-16.73-18.75-10.4-5.65-1.78
Depreciation & Amortization
3.242.550.230.020.010.010.0100
Share-Based Compensation
11.1419.5315.012.041.571.231.050.750
Other Operating Activities
-2.24-4.09-5.4810.31.527.941.860.440.53
Operating Cash Flow
-52.04-70.99-40.59-21.91-13.36-8.79-6.61-4.45-1.25
Capital Expenditures
0.76-1.54-1.47-0.06-0.03-0.03-0.01-0.020
Acquisitions
0-3.2-2.25000000
Investing Cash Flow
0.76-4.74-3.72-0.06-0.03-0.03-0.01-0.020
Share Issuance / Repurchase
1.790.7749.7916.395.4813.850.074.31.18
Debt Issued / Paid
9.9235.23-14.9716.75.9424.8400
Other Financing Activities
19.462.2269.49-0.09-0.03-0.342.65--
Financing Cash Flow
31.1738.21104.3133.0111.3815.57.564.31.18
Net Cash Flow
-20.11-37.516011.04-26.690.95-0.18-0.07
Free Cash Flow
-51.28-72.53-42.06-21.97-13.38-8.81-6.61-4.48-1.25
Free Cash Flow Margin
-2091.27%-19237.40%-8412.00%------
Free Cash Flow Per Share
-7.09-12.21-8.14-6.95-6.65-5.93-7.35-5.18-1.66
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).